Key Takeaways
- Amazon Web Services (AWS) is grappling with significant API errors and connectivity issues in its US-EAST-1 region, affecting thousands of users and numerous global services, with the root cause identified as a DNS resolution issue with DynamoDB.
- Spot gold prices have extended gains, rising nearly 2% to $4,333.90/oz, while the Nasdaq 100 climbed over 1% and the S&P 500 advanced 0.8%, reflecting notable market movements.
- Morgan Stanley has downgraded Progressive Corp. (PGR) to Underweight from Equal-Weight, simultaneously cutting its target price to $214 from $265.
- Geopolitical developments include French President Emmanuel Macron announcing a "Coalition of the Willing" meeting on Ukraine in London this Friday, and Israeli Prime Minister Benjamin Netanyahu engaging in diplomatic discussions with US Vice President JD Vance amidst ongoing military operations against Hamas.
- Roche (RHHBY) has secured FDA approval for its drug Gazyva/Gazyvaro for the treatment of Lupus Nephritis, offering a new, more convenient therapeutic option for adult patients.
AWS Outage Disrupts Global Services
Amazon Web Services (AWS) is currently investigating and working to resolve significant API errors and connectivity issues primarily affecting its US-EAST-1 region. The disruption has impacted thousands of users in the US, with Downdetector reporting problems for approximately 3,550 users. AWS has confirmed that the underlying issue appears to be related to a DNS resolution problem with the DynamoDB API endpoint in the affected region.
Multiple mitigations have been applied across various Availability Zones in US-EAST-1, but the platform is still experiencing elevated errors for new EC2 instance launches, prompting AWS to rate-limit these launches to aid recovery. While initial signs of recovery are being observed across most affected services, a backlog of queued requests for services like Lambda and Cloudtrail continues to be processed. The widespread outage has affected numerous popular applications, websites, and games, including Snapchat, Roblox, Fortnite, and several banking services, highlighting the internet's reliance on major cloud providers.
Market Sees Gold Surge, Equity Gains
In market news, spot gold has extended its impressive gains, rising by nearly 2% to trade at $4,333.90 per ounce. Simultaneously, equity markets showed positive momentum, with the Nasdaq 100 climbing by more than 1% and the S&P 500 increasing by 0.8%. These movements reflect dynamic trading conditions across commodities and major stock indices.
Progressive Corp. Downgraded by Morgan Stanley
Morgan Stanley has adjusted its rating for Progressive Corp. (PGR), downgrading the insurance giant from Equal-Weight to Underweight. Accompanying this downgrade, the firm significantly cut its target price for Progressive shares to $214 from a previous $265. This revised outlook from Morgan Stanley suggests a more cautious stance on the insurer's near-term performance and market valuation.
Geopolitical Landscape: Ukraine, Russia, and Middle East Diplomacy
French President Emmanuel Macron, speaking in Slovakia, announced that a meeting of Ukraine's "Coalition of the Willing" will take place this Friday in London. This follows reports that Macron and British Prime Minister Keir Starmer are set to co-chair such a leaders'-level meeting, which has previously focused on security guarantees for Ukraine and discussions regarding potential summits between Ukrainian President Zelenskyy and Russian President Putin.
Meanwhile, Israeli Prime Minister Benjamin Netanyahu stated his intention to discuss diplomatic opportunities with US Vice President JD Vance during Vance's upcoming visit to Israel. This comes as Netanyahu confirmed that Israel attacked Hamas with 153 tons of bombs in response to a ceasefire violation, emphasizing a commitment to defeating Hamas militarily and politically. Vance's visit is expected to include discussions on an interim arrangement for Gaza and a pilot reconstruction plan. Separately, the Russian Foreign Ministry reported a constructive discussion on concrete steps to implement understandings reached during a call between Trump and Putin.
Roche's Gazyva/Gazyvaro Gains FDA Approval for Lupus Nephritis
In pharmaceutical news, Roche (RHHBY) has received FDA approval for its drug Gazyva/Gazyvaro for the treatment of Lupus Nephritis. This approval is for adult patients receiving standard therapy and includes a shorter 90-minute infusion time for eligible individuals. The decision is based on positive results from Phase II NOBILITY and Phase III REGENCY studies, which demonstrated improved efficacy, with nearly half of patients achieving a complete renal response when treated with Gazyva in combination with standard therapy, compared to 33.1% on standard therapy alone. This marks a significant advancement in treatment options for the autoimmune kidney disease.
ECB's Schnabel on Euro's Global Position; US Leveraged Finance Stable
European Central Bank (ECB) Executive Board member Isabel Schnabel has asserted that the euro's global position remains strong and should be further strengthened. Schnabel highlighted a "window of opportunity" to enhance the euro's international role as investors look to diversify their portfolios and turn towards Europe, a sentiment echoed by other European policymakers.
Finally, Fitch Ratings has indicated that US Leveraged Finance is not showing classic bubble signs, providing a stable outlook for this segment of the financial market.
US Supreme Court to Hear Gun Rights Case
The U.S. Supreme Court is set to hear the Trump administration's defense of a federal law that bars illegal drug users from owning guns. This highly anticipated case will address conflicting rulings from lower courts regarding whether such prohibitions violate the Second Amendment, particularly in the context of marijuana use, which is legal in many states but remains illegal federally. Arguments are expected to take place in early 2026.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.